MedPath

A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System

Not Applicable
Completed
Conditions
Cardiac Arrhythmia
Interventions
Device: An innovative 3-lead wireless water resistant Holter device
Device: A conventional device
Registration Number
NCT04723355
Lead Sponsor
Hospital Israelita Albert Einstein
Brief Summary

Holter monitoring is one of the most widely used diagnostic methods to detect cardiac arrhythmias. Newer Holter monitors may provide some advantages over the more traditional ones. This study will compare the findings of a Holter exam using an innovative 3-lead wireless water resistant device with a conventional device.

Detailed Description

The 24-hour ambulatory electrocardiography, commonly known as Holter monitoring, is a diagnostic method to correlate clinical symptoms with cardiac arrhythmias. The Holter monitor records electrical signals from the heart using electrodes attached to the chest, which are connected via cables to a digital recorder. In addition to the device to record the cardiac electrical signals, the Holter system also has a software for review and analysis of the record. The software of the Holter system has an integrated automatic analysis process to detect different sorts of heart beats, rhythms, etc, which are then validated by a technician and a physician. The success of the automatic analysis depends of the quality of the captured electrical signals, which are dependent on the appropriate attachment of the electrodes/cables to the patient body. Therefore, inappropriately attached electrodes/cables can result in electromagnetic disturbance that can interfere with the ECG signal, resulting in a very noisy record that is hard to be analysed.

Newer Holter systems that eliminate the cables and attach the recorder directly to the electrodes positioned in the patient´s chest might reduce the electromagnetic disturbance in the ECG signal capture and, therefore, improve the quality of the exam.

This study will compare the findings of a Holter exam using an innovative 3-lead wireless water resistant device with a conventional device.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
231
Inclusion Criteria
  • Any individual who has an indication of 24 hours Holter monitoring and is referred to the arrhythmia clinic of the Instituto Dante Pazzanese de Cardiologia
Exclusion Criteria
  • Refusal to provide written informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Holter deviceAn innovative 3-lead wireless water resistant Holter deviceIn this single arm of the study, the participant will use 2 Holter systems simultaneously for 24 hours, an innovative 3-lead wireless water resistant device and a conventional device.
Holter deviceA conventional deviceIn this single arm of the study, the participant will use 2 Holter systems simultaneously for 24 hours, an innovative 3-lead wireless water resistant device and a conventional device.
Primary Outcome Measures
NameTimeMethod
Detection of Cardiac Arrhythmias24 hours

Number of patients with cardiac arrhythmias detected in both Holter monitors, including a) atrial fibrillation or atrial flutter; b) supraventricular tachycardia (any tachycardia with ≥ 3 beats arising outside the sinus node and above the His-Purkinje bifurcation, including atrial tachycardia, atrioventricular nodal reentry tachycardia, junctional tachycardia and accessory pathway reentry tachycardia, except atrial fibrillation and atrial flutter); c) ventricular tachycardia (any tachycardia with ≥ 3 beats arising from the ventricles, except polymorphic ventricular tachycardia or ventricular fibrillation); d) polymorphic ventricular tachycardia or ventricular fibrillation; e) atrioventricular (AV) block (high-degree AV block, in which there is an interruption in the transmission of a heart beat from the atria to the ventricles, including those classified as 2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block); or f) heart beat pauses (≥ 2,5 seconds)

Secondary Outcome Measures
NameTimeMethod
Detection of Atrial Fibrillation or Atrial Flutter24 hours

Number of patients with atrial fibrillation or atrial flutter detected in both Holter monitors

Detection of Supraventricular Tachycardia24 hours

Number of patients with supraventricular tachycardia (any tachycardia with ≥ 3 beats arising outside the sinus node and above the His-Purkinje bifurcation, including atrial tachycardia, atrioventricular nodal reentry tachycardia, junctional tachycardia and accessory pathway reentry tachycardia, except atrial fibrillation and atrial flutter) detected in both Holter monitors

Detection of Ventricular Tachycardia24 hours

Number of patients with ventricular tachycardia (any tachycardia with ≥ 3 beats arising from the ventricles, except polymorphic ventricular tachycardia or ventricular fibrillation) detected in both Holter monitors

Detection of Polymorphic Ventricular Tachycardia or Ventricular Fibrillation24 hours

Number of patients with polymorphic ventricular tachycardia or ventricular fibrillation detected in both Holter monitors

Detection of Atrioventricular Block24 hours

Number of patients with atrioventricular block (high-degree AV block, in which there is an interruption in the transmission of a heart beat from the atria to the ventricles, including those classified as 2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block) detected in both Holter monitors

Detection of Heart Beat Pauses24 hours

Number of patients with heart beat pauses ≥ 2.5 seconds detected in both Holter monitors

Duration of the Holter Exam24 hours

Duration of the Holter exam in both Holter monitors

Mean Heart Rate24 hours

Mean heart rate measured in both Holter monitors

Maximum Heart Rate24 hours

Maximum heart rate measured in both Holter monitors

Minimum Heart Rate24 hours

Minimum heart rate measured in both Holter monitors

Atrial Ectopic Heart Beats24 hours

Total number of atrial ectopic heart beats measured in both Holter monitors

Ventricular Ectopic Heart Beats24 hours

Total number of ventricular ectopic heart beats measured in both Holter monitors

Episodes of Ventricular Tachycardia24 hours

Total number of ventricular tachycardia episodes detected in both Holter monitors

Episodes of Supraventricular Tachycardia24 hours

Total number of supraventricular tachycardia episodes detected in both Holter monitors

Episodes of Heart Beat Pauses24 hours

Total number of heart beat pauses ≥ 2.5 seconds detected in both Holter monitors

Holter System Convenience of Use24 hours

Number of Participants Reporting the convenience of use of the Holter systems

Trial Locations

Locations (1)

Instituto Dante Pazzanese de Cardiologia

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath